as on December 26, 2025 at 10:37 pm IST
Day's Low
Day's High
2.88%
Downside
4.68%
Upside
52 Week's Low
52 Week's High
38.85%
Downside
238.19%
Upside
Check Kure Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$38.6M
EPS (TTM)
-4.56
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-207.36%
Compare market cap, revenue, PE, and other key metrics of Kure Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $38.6M | NA | NA | 0.00% | |
| BUY | $37.8B | 401.04% | -16.34 | -264.83% | |
| BUY | $52.9B | 191.28% | 1252.16 | 1.36% | |
| BUY | $118.7B | 97.47% | 32.35 | 31.35% | |
| BUY | $83.1B | 60.29% | 18.8 | 32.13% |
The Kure Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kure Therapeutics Inc investment value today
Current value as on today
₹39,231
Returns
Returns from Kure Therapeutics Inc Stock
Dollar Returns*
₹5,287 (+5.29%)
Search interest for Kure Therapeutics Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 816.9% return, outperforming this stock by 903.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 151.1% return, outperforming this stock by 216.3%
Price Dip
![]()
In the last 7 days, OKUR stock has moved down by -5.3%
| Organisation | Kure Therapeutics Inc |
| Headquarters | 6707 Winchester Circle, Boulder, CO, United States, 80301 |
| CEO | Dr. Nicholas A. Saccomano Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Dylan Hartley Ph.D. | Chief Scientific Officer |
Ms. Roberta Alton | Senior VP of Clinical Operations |
Dr. Kevin S. Litwiler Ph.D. | Senior Vice President of DMPK & Clinical Pharmacology |
Dr. Mark L. Boys Ph.D. | Senior Vice President of Discovery Chemistry |
Dr. Nicholas A. Saccomano Ph.D. | President, CEO & Director |
Mr. Jason A. Leverone CPA | Chief Financial Officer |
Dr. Samuel Agresta M.D., M.P.H. | Chief Medical Officer |
Mr. Rogan P. Nunn J.D. | General Counsel & Secretary |
Dr. James Blake Ph.D. | Senior Vice President of Computational Drug Discovery |
Kure Therapeutics Inc share price today is $2.78 as on . Kure Therapeutics Inc share today touched a day high of $2.91 and a low of $2.7.
Kure Therapeutics Inc share touched a 52 week high of $9.4 on and a 52 week low of $1.7 on . Kure Therapeutics Inc stock price today i.e. is trending at $2.78,which is 70.43% down from its 52 week high and 63.53% up from its 52 week low.
Kure Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kure Therapeutics Inc (OKUR) shares with as little as ₹89.767 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.67 in Kure Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kure Therapeutics Inc share’s latest price of $2.78 as on December 26, 2025 at 10:37 pm IST, you will get 3.5971 shares of Kure Therapeutics Inc. Learn more about
fractional shares .